Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)

被引：0

作者：

Evelina Miele

Gian Paolo Spinelli

Federica Tomao

Angelo Zullo

Filippo De Marinis

Giulia Pasciuti

Luigi Rossi

Federica Zoratto

Silverio Tomao

机构：

[1] Department of Experimental Medicine University of Rome "Sapienza" viale Regina Elena 324,Operative Unit of Medical Oncology, S. Maria Goretti Hospital

[2] University of Rome "Sapienza" – Latina-via Canova,Gastroenterology and Digestive Endoscopy

[3] "Nuovo Regina Margherita" Hospital,Thoracic Oncology Unit I, Department of Lung Diseases

[4] San Camillo and Forlanini Hospitals,undefined

来源：

Journal of Experimental & Clinical Cancer Research | / 27卷

关键词：

Positron Emission Tomography; Small Cell Lung Cancer; Mediastinal Lymph Node; Mediastinal Lymph Node Metastasis; Positron Emission Tomography Examination;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

PET (Positron Emission Tomography) is a nuclear medicine imaging method, frequently used in oncology during the last years. It is a non-invasive technique that provides quantitative in vivo assessment of physiological and biological phenomena. PET has found its application in common practice for the management of various cancers.

引用

共 50 条

[21] Reproducibility of [18F] fluoro-2-deoxy-D-glucose (FDG) measurements in non-small cell lung cancer (NSCLC) using PET.
Hoekstra, CJ
Hoekstra, OS
Stroobants, SG
Lammertsma, AA
JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 293P - 293P
[22] Utility of positron emission tomography (PET) in potentially resectable patients with non-small cell lung carcinoma (NSCLC)
Wigfield, C
Bobadilla, JL
Perlman, S
Pratt, T
Edwards, NM
Weigel, TL
CHEST, 2004, 126 (04) : 741S - 742S
[23] Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16α-18F-fluoro-17β-estradiol PET
Yoshio Yoshida
Tetsuji Kurokawa
Tetuya Tsujikawa
Hidehiko Okazawa
Fumikazu Kotsuji
Journal of Ovarian Research, 2
[24] Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16α-18F-fluoro-17β-estradiol PET
Yoshida, Yoshio
Kurokawa, Tetsuji
Tsujikawa, Tetuya
Okazawa, Hidehiko
Kotsuji, Fumikazu
JOURNAL OF OVARIAN RESEARCH, 2009, 2 (01):
[25] Interest of Fluoro-Deoxy-Glucose (FDG) Positron Emission Tomography (PET) in the preoperative evaluation of breast cancer
Soler, C.
Bouteille, C.
Geissler, B.
Steiner-Emptaz, A.
Gremillet, E.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S328 - S328
[26] Update on F-18-fluoro-deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer
Usmanij, Edwin A.
de Geus-Oei, Lioe-Fee
Bussink, Jan
Oyen, Wim J. G.
CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (04) : 314 - 321
[27] Survival and central photopenia detected by fluorine-18 fluoro-deoxy-glucose positron emission tomography (FDG-PET) in patients with locoregional non-small cell lung cancer treated with radiotherapy
Cox, Richard Ashley
Akhurst, Tim
Bressel, Mathias
MacManus, Michael
Ball, David
RADIOTHERAPY AND ONCOLOGY, 2017, 124 (01) : 25 - 30
[28] Vasculo-Belnet disease complicated by conversion disorder diagnosed with 18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography (PET/CT)
Furuya, Makiko Yashiro
Temmoku, Jumpei
Fujita, Yuya
Matsuoka, Naoki
Asano, Tomoyuki
Sato, Shuzo
Kobayashi, Hiroko
Watanabe, Hiroshi
Migita, Kiyoshi
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2019, 65 (02) : 55 - 60
[29] The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases
Hernández, GR
Avalos, CRDY
Delgado, JLC
MEDICINA CLINICA, 2005, 124 (06): : 229 - 236
[30] The clinical impact of positron emission tomography (PET) scanning on the staging and management of non small cell lung cancer (NSCLC)
Mackay, A. J.
Docherty, C.
Beckles, M.
Buscombe, J.
LUNG CANCER, 2007, 57 : S1 - S1

← 1 2 3 4 5 →